BD, Medtronic To Introduce New Infusion Set With BD FlowSmart Technology

(RTTNews) - BD Medical, a segment of medical technology company Becton, Dickinson and Co.(BDX), and Medtronic (MDT) Monday unveiled a collaboration to introduce a new insulin pump infusion set with BD FlowSmart technology.

An insulin infusion set delivers insulin from the pump to the body and is a crucial part of the overall pump system.

As part of the agreement, Medtronic will commercialize the infusion set, while BD will manufacture the product.

The infusion set recently received FDA clearance and Health Canada approval and is expected to be launched in 2016.

An application has been submitted for CE marking. It is designed to work with both Medtronic insulin pumps and most other manufacturers' insulin pumps.